Physician profile
Christopher W Doti
NPI 1053380477
$1,155.98
in general payments reported to CMS, 2019-2025
7 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.57 · 2022: $481 · 2023: $205 · 2024: $249 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $398.15 | 2021-2025 | Eluvia, Seismiq Lithotrip_pi, General - Thrombectomy |
| Bard Peripheral Vascular, INC. | $297.17 | 2022 | |
| Inari Medical, INC. | $219.72 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $85.97 | 2023 | Mvp, Concertotm |
| Angiodynamics, INC. | $74.96 | 2023-2024 | Micro Access, Smart Port Ct |
| Stryker Corporation | $51.83 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Target |
| Microvention, INC. | $28.18 | 2025 | Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Doti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.